Kinea Bio
Phase 2Kinea Bio was founded in 2020 by highly-respected scientific leaders in the neuromuscular disease space with a history of bench-to-bedside innovations.
Founded
2020
Focus
RNA & Gene Therapy
About
Kinea Bio was founded in 2020 by highly-respected scientific leaders in the neuromuscular disease space with a history of bench-to-bedside innovations.
Funding History
1Total raised: $12M
Seed$12MUndisclosedMay 15, 2022
Company Info
TypePrivate
Founded2020
LocationCambridge, United States
StagePhase 2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile